Atlantic Bridge

Trustap Ltd is a transaction platform based in Carrigaline, Ireland, founded in 2016. The company's primary focus is to enhance security for buyers and sellers engaging in online or in-person transactions with strangers. Trustap operates as a personal escrow service, acting as a neutral third party that holds funds securely until both parties are satisfied with the transaction. This innovative approach aims to minimize the risk of scams, as it only releases the money once transaction milestones are met and any complaint periods have elapsed. By providing a reliable and secure payment technology, Trustap enables users to conduct transactions with greater confidence and peace of mind.

Trustap Ltd is a transaction platform based in Carrigaline, Ireland, founded in 2016. The company's primary focus is to enhance security for buyers and sellers engaging in online or in-person transactions with strangers. Trustap operates as a personal escrow service, acting as a neutral third party that holds funds securely until both parties are satisfied with the transaction. This innovative approach aims to minimize the risk of scams, as it only releases the money once transaction milestones are met and any complaint periods have elapsed. By providing a reliable and secure payment technology, Trustap enables users to conduct transactions with greater confidence and peace of mind.

Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovation aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant global market given the high prevalence of diabetic foot ulcers.

Trustap Ltd is a transaction platform based in Carrigaline, Ireland, founded in 2016. The company's primary focus is to enhance security for buyers and sellers engaging in online or in-person transactions with strangers. Trustap operates as a personal escrow service, acting as a neutral third party that holds funds securely until both parties are satisfied with the transaction. This innovative approach aims to minimize the risk of scams, as it only releases the money once transaction milestones are met and any complaint periods have elapsed. By providing a reliable and secure payment technology, Trustap enables users to conduct transactions with greater confidence and peace of mind.

Kastus is an award-winning surface innovation company based in Ireland, founded in 2014 by John Browne after over a decade of research and development. The company specializes in patented antiviral and antibacterial surface coatings designed to enhance hygiene on various surfaces, particularly glass and ceramics. Kastus' technology has been validated by ISO standards and proven to kill over 99% of harmful bacteria, viruses, fungi, and antibiotic-resistant superbugs, including human coronavirus. This makes it highly effective for products that require continuous touch hygiene. In response to the COVID-19 pandemic, Kastus launched antiviral and antimicrobial screen protectors to help businesses reopen safely. The company has also received EU funding for developing innovative solutions to combat Covid-19.

Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.

Neurent Medical Limited is a medical device company based in Galway, Ireland, founded in 2015 by Brian Shields and David Townley. The company specializes in developing non-surgical treatments for inflammatory sino-nasal diseases, specifically focusing on chronic rhinitis. Neurent Medical offers a single-use, minimally invasive device designed for ENT surgeons, which utilizes a hand-held radio-frequency mechanism. This device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization, where it deploys a microelectrode array to deliver targeted energy. This intervention interrupts the autonomic function of the mucosal structures in the nasal cavities, effectively reversing the inflammatory cascade. By enabling treatment in an office setting, Neurent Medical aims to eliminate the complications and costs typically associated with traditional surgical procedures for rhinitis.

iQuate Limited, acquired by HyperGrid Inc. in 2020, specializes in network management software that aids large enterprises in IT discovery, inventory, and measurement. The company provides a suite of tools, including iQSonar, a platform for discovering and analyzing devices on networks, and iQAnalytics, which offers detailed inventory and deployment analysis. iQuate's solutions support software asset management, IT asset management, and compliance for major vendors like Oracle, Microsoft, and IBM. Additionally, the company offers IT cost optimization services and various training courses for clients and partners. Its customer base spans multiple sectors, including transportation, healthcare, telecommunications, and energy. Founded in 2002 and headquartered in Dublin, Ireland, with regional offices in San Francisco and London, iQuate is recognized for its capabilities in managing IT complexities and optimizing software licensing positions.

Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.

ApisProtect is an Irish company based in Cork, founded in 2017, that specializes in agricultural technology for beekeeping. It develops an Internet of Things (IoT) system equipped with in-hive sensors and mobile/web apps to monitor bee colonies continuously. This system uses cellular and satellite-powered communication to track hive conditions, health, and activity levels. By employing big data and machine learning techniques, ApisProtect helps beekeepers detect diseases and pests, assess productivity, and prevent losses, ultimately improving the efficiency of pollination and honey production without requiring frequent manual checks.

Neurent Medical Limited is a medical device company based in Galway, Ireland, founded in 2015 by Brian Shields and David Townley. The company specializes in developing non-surgical treatments for inflammatory sino-nasal diseases, specifically focusing on chronic rhinitis. Neurent Medical offers a single-use, minimally invasive device designed for ENT surgeons, which utilizes a hand-held radio-frequency mechanism. This device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization, where it deploys a microelectrode array to deliver targeted energy. This intervention interrupts the autonomic function of the mucosal structures in the nasal cavities, effectively reversing the inflammatory cascade. By enabling treatment in an office setting, Neurent Medical aims to eliminate the complications and costs typically associated with traditional surgical procedures for rhinitis.

Accuris Networks, a subsidiary of ZephyrTel, Inc., specializes in providing roaming, carrier Wi-Fi, and interworking solutions for communication service providers. Founded in 1997 and headquartered in Dublin, Ireland, with additional offices in Boston and Kuala Lumpur, the company offers a range of products including eAAA, a 3GPP server for authentication, authorization, and accounting, and various platforms for Wi-Fi integration and management. Its AccuROAM platform enables seamless connectivity across mobile broadband networks such as GSM, CDMA, LTE, and Wi-Fi, ensuring secure data, voice, and messaging services for subscribers both domestically and internationally. The company also delivers solutions for sponsored roaming services, VoIP, and cloud-based mediation and billing for Wi-Fi data usage. Accuris Networks has established strategic partnerships with industry players like Autelan and Total Software Solutions, enhancing its offerings in the evolving telecommunications landscape.

Biosensia Ltd. is a Dublin-based company specializing in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic system designed to deliver both quantitative and qualitative laboratory test results. This system features a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. RapiPlex facilitates near-patient care by providing rapid and practical testing solutions across various applications, including theranostic identification and monitoring, as well as veterinary and food safety testing. The platform is compatible with multiple biological sample types, such as whole blood, plasma, serum, urine, saliva, and milk. Founded in 2000 and previously known as NanoComms Ltd., Biosensia Ltd. rebranded in 2006 and currently operates as a subsidiary of Kypha Inc.

Biosensia Ltd. is a Dublin-based company specializing in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic system designed to deliver both quantitative and qualitative laboratory test results. This system features a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. RapiPlex facilitates near-patient care by providing rapid and practical testing solutions across various applications, including theranostic identification and monitoring, as well as veterinary and food safety testing. The platform is compatible with multiple biological sample types, such as whole blood, plasma, serum, urine, saliva, and milk. Founded in 2000 and previously known as NanoComms Ltd., Biosensia Ltd. rebranded in 2006 and currently operates as a subsidiary of Kypha Inc.

GloNav is a technology company specializing in global positioning system (GPS) and satellite navigation products aimed at the wireless handset and mobile consumer electronics markets. Founded in 2006 and headquartered in Newport Beach, California, GloNav develops a range of products, including GPS radio frequency integrated circuits and single-chip assisted GPS solutions, which facilitate low dropout tracking and integration into cellular handsets. The company's offerings also encompass GPS baseband intellectual property, satellite acquisition and navigation software, and ultra-low power radio frequency integrated circuit technology. GloNav operates from multiple locations, including the United States, the United Kingdom, Ireland, and Taiwan, and has been a subsidiary of NXP B.V. since early 2008.

PolarLake Limited specializes in integration technology solutions, focusing on the financial services sector and other industries such as government, telecommunications, and manufacturing. Founded in 1999 and headquartered in Dublin, Ireland, the company offers a range of products designed to facilitate data sharing and distribution. Its notable offerings include a Financial Markets Reference Data Distribution solution, which benefits both buy-side and sell-side firms, as well as fund administrators and custodians. The Integration Suite allows organizations to share data and business logic effectively, while the Integration Suite Finance Edition addresses the specific integration challenges faced by financial services organizations. Additionally, PolarLake provides applications for managing OTC derivatives, including reconciliation and trade lifecycle management, alongside a Messaging Integrator to enhance communication across platforms.